1. Medtech Insight
  2. >>Business

LabCorp Broadens Women's Health Offering With Sequenom Buy

 
• By Tina Tan

LabCorp's maiden acquisition of 2016 is Sequenom, one of the pioneers in noninvasive prenatal testing.

Laboratory Corp. of America Holdings is acquiring noninvasive prenatal testing (NIPT) specialist Sequenom Inc. in a $302m all-cash deal. LabCorp described the transaction as "highly strategic," enabling it to broaden out its test offerings in women's health and expand its geographic reach, among other things.

Under the terms of the agreement, LabCorp would acquire all outstanding shares of Sequenom in a cash tender offer for $2.40 per share, equivalent to an equity value of $302m....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Medtech Insight

German Bionic Launches ‘Strongest Exoskeleton To Date’

 
• By Natasha Barrow

German Bionic’s new exoskeleton Exia helps healthcare practitioners, nurses, and other caregivers to lift and move patients by supporting muscle movement and reducing the risk of injury.

Medtronic Eyes Up to $350M Tariff Hit in FY26, Leans On Cost Controls And Pricing Strategy

 
• By Shubham Singh

Medtronic expects operating profit to grow approximately 7% in fiscal 2026, excluding tariff impacts. If tariffs materialize at the upper end of the projected range, operating profit growth could drop by 2.2 to 3.2 percentage points.

India-UK Free Trade Agreement Sets Stage For Medtech Growth, But Industry Demands Safeguards

 
• By Shubham Singh

Announced after three years of negotiation, the FTA eliminates tariffs on 99% of Indian product types, covering nearly all trade value, and reduces tariffs on 90% of UK products. Although not yet formally signed, the deal is being positioned by the Indian government as “transformative,” with an estimated economic impact of $6.4bn for the UK alone by 2040.